Article
23 Jan 2024
Recent Settlement Highlights Increased Focus On Clinical Research Enforcement And Risks For Clinical Trial Billing
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
16 Nov 2023
OIG Publishes General Compliance Program Guidance For The Health Care Industry
Article
27 Oct 2023
FDA Updates Off-Label Communications Guidance
Article
27 Feb 2023
California's Novel Enforcement Against Mail Order Drug Company Reflects New Level Of Scrutiny For Telehealth Platform Companies
Article
15 Dec 2022
All Eyes On Influencers: How Life Sciences Companies Effectively Navigate The World Of Social Media
Article
24 Oct 2022
FDA Releases Significantly Revised Final Clinical Decision Support Software Guidance And Related Changes
Article
22 Jul 2022
OIG Advisory Opinion On Continuing Education Provides Insight On Risk Areas
Article
07 Jun 2022
FTC Proposed Updates To Endorsement Guides And .com Disclosures Guidance Signal Continued Regulatory Focus On Influencers And Social Media
Article
16 Feb 2022
FDA Releases Proposed Rules On National Licensure Standards For Wholesale Drug Distributors And Third-Party Logistics Providers (3PLs)
Article
29 Jul 2021
Update: Use Of Real-World Evidence In FDA Approvals And Product Promotion